Estimated number of deaths directly averted in people 60 years and older as a result of COVID-19 vaccination in the WHO European Region, December 2020 to November 2021.
Efficacité et sécurité des vaccins, médicaments et produits de santé - Qualité des laboratoires médicaux
Téléchargement 390.11 KoPeer reviewed scientific article
Anglais
Auteurs
Margaux Mi Meslé [3]; Jeremy Brown [4]; Piers Mook [5]; José Hagan [6]; Roberta Pastore [7]; Nick Bundle [8]; Gianfranco Spiteri [9]; Giovanni Ravasi [10]; Nathalie Nicolay [11]; Nick Andrews [12]; Tetiana Dykhanovska [13]; Mossong, Joel [14]; Małgorzata Sadkowska-Todys [15]; Raina Nikiforova [16]; Flavia Riccardo [17]; Hinta Meijerink [18]; Clara Mazagatos [19]; Jan Kyncl [20]; Jim McMenamin [21]; Tanya Melillo [22]; Stella Kaoustou [23]; Daniel Lévy-Bruhl [24]; Freek Haarhuis [25]; Rivka Rich [26]; Meaghan Kall [27]; Dorit Nitzan [28]; Catherine Smallwood [29]; Pebody, Richard G [30]Mots-clés
Résumé:
Since December 2019, over 1.5 million SARS-CoV-2-related fatalities have been recorded in the World Health Organization European Region — 90.2% in people ≥ 60 years. We calculated lives saved in this age group by COVID-19 vaccination in 33 countries from December 2020 to November 2021, using weekly reported deaths and vaccination coverage. We estimated that vaccination averted 469,186 deaths (51% of 911,302 expected deaths; sensitivity range: 129,851-733,744; 23-62%). Impact by country ranged 6-93%, largest when implementation was early.